Skip to main content

Table 1 Demographic and clinical data of the six renal anemia patients in our study

From: Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat

 

T0

T1

P-value

Age [years]

49.67 ± 18.82

49.67 ± 18.82

–

Sex (M/F)

1/5

1/5

–

Hemoglobin(g/l)

82.67 ± 12.04

90.67 ± 15.80

0.05

Erythrocytic count

2.83 ± 0.50

3.12 ± 0.87

0.20

HCT

26.90 ± 5.96

28.43 ± 6.49

0.38

Low-density lipoprotein(mmol/l)

2.12 ± 0.53

1.45 ± 0.57

0.02

Triglycerides(mmol/l)

2.44 ± 1.66

1.78 ± 1.6

0.10

Total cholesterol(mmol/l)

3.91 ± 0.56

2.66 ± 0.45

0.07

  1. Table showed levels of HB, erythrocytic count, HCT, and lipids before (T0) and after 1 month (T1) of roxadustat treatment. The average (± standard deviation) values are reported